Digital solution and service (e.g. application/digital health portal/platform/AI based system/etc.)
Short description
Evidence
No impact-related evidence is currently available
Maturity
There is evidence for economic viability and/or of benefits to the target group of the practice. Further research/development is needed for routine use.
The product is commercially available as a paid SaaS (professional plan, 14-day trial). We do not publish user counts, job-creation figures or other impact metrics, so we do not claim the ‘proven market impact’ maturity level.
Countries
Spain
Geographical scope
European
Developed and operated from Spain. The product is a web application available to professionals in Spanish, English and Catalan.
Language(s)
Spanish, English, Catalan
Comment
We do not publish a count of sites or users. The product is publicly available at https://nexmin.ai with a 14-day trial.
Submitted in other database or repository of digital health resources that is publicly available
Submitted for editorial review to TheraIndex (https://theraindex.com) and Mytherapist Tools (https://www.mytherapist.tools); not yet publicly listed. Product website: https://nexmin.ai
Additional information
Relations
to clinicians / care practitioners
Health data analytics (Artificial Intelligence/algorithm development and calibration/machine learning/risk stratification tools/etc.) Other (please define below)
Clinical documentation and session notes for psychologists, therapists and coaches. AI copilot: the professional validates every draft.
to patients / citizens
Telehealth and telemedicine
Addressed prevention area(s)
Mental health
Ready to be transferred to
Ready for transfer, but the practice has not been transferred yet.